Pfizer Inc and German biotech firm BioNTech SE will get $1.95 billion from the U.S. government to produce and deliver 100 million doses of their COVID-19 vaccine candidate, the companies said on Wednesday.
FILE PHOTO: The logo of U.S. pharmaceutical corporation Pfizer Inc. is seen at a branch in Zurich, Switzerland October 2, 2018. REUTERS/Arnd Wiegmann
The Trump administration has agreed to spend billions of dollars for the development and procurement of a potential vaccine. The administration launched ‘Operation Warp Speed’ — a joint HHS and Department of Defense program — to accelerate the development of coronavirus vaccines, treatments and diagnostics.
The aim is to produce vaccines that can end the pandemic by protecting billions of people from infection or severe illness.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Britain Secures 90 Million Doses Of Potential Coronavirus Vaccines From Pfizer, BioNTech & ValnevaAn effective vaccine is yet to be proven, however the U.K. has now secured access to up to 230 million vaccine doses.
Read more »
Britain secures 90 million possible COVID-19 vaccine doses from Pfizer/BioNTech, ValnevaBritain has signed deals to secure 90 million doses of two possible COVID-19 vaccines from an alliance of Pfizer Inc and BioNTech , and French group Valneva , the business ministry said on Monday.
Read more »
Pfizer-BioNTech potential coronavirus vaccine shows promise in second early trialGerman biotech BioNTech and U.S. drugmaker Pfizer Inc on Monday said data from an early-stage trial of their experimental coronavirus vaccine showed that it prompted an immune response and was well-tolerated, similar to results seen in prior early test.
Read more »
Pfizer-BioNTech potential COVID-19 vaccine shows promise in additional dataGerman biotech firm BioNTech and U.S. drugmaker Pfizer on Monday reported additional data from their experimental COVID-19 vaccine that showed it was safe and induced an immune response in patients.
Read more »
Pfizer, BioNTech Get $1.95 Billion Covid-19 Vaccine Order From U.S. GovernmentPfizer and BioNTech said they have signed a $1.95 billion agreement with the U.S. Department of Health and Human Services and the Defense Department for millions of doses of a Covid-19 vaccine which Americans would receive for free.
Read more »
U.S. government taps Pfizer to produce millions of doses of coronavirus vaccineThe vaccine is being jointly developed by German biotech firm BioNTech and U.S.-based Pfizer.
Read more »